Poltreg

Poltreg Minority Interest

Minority Interest (Non-Controlling Interest) of Poltreg (PTG.WA) as of Oct 25, 2026.

Minority Interest

-PLN

Last updated:

Minority Interest (Non-Controlling Interest) of Poltreg is 2026 - PLN. Minority Interest (Non-Controlling Interest) of Poltreg was 2025 - PLN. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Poltreg Stock analysis

What does Poltreg do? Poltreg SA, based in Gdansk, Poland, develops and commercializes patented TREG methods for treating autoimmune diseases. The company focuses on therapies using T-regulated cells, targeting conditions like type one and type two diabetes and multiple sclerosis. With 18 employees, Poltreg SA conducts research in collaboration with scientific specialists and is building its own research center to advance future studies. Poltreg is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Poltreg stock

On Eulerpool you can find the complete historical development of Minority Interest (Non-Controlling Interest) Poltreg since 2006 – with annual values, charts, and detailed analysis.

Minority interest represents the portion of subsidiaries not owned by the parent company. It reflects third-party ownership stakes in consolidated entities.

Minority Interest (Non-Controlling Interest)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Minority Interest (Non-Controlling Interest)'s Poltreg historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Poltreg

All Key Metrics — Poltreg